I‐Chen Chen

546 total citations
43 papers, 346 citations indexed

About

I‐Chen Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, I‐Chen Chen has authored 43 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in I‐Chen Chen's work include Pulmonary Hypertension Research and Treatments (8 papers), Trauma Management and Diagnosis (6 papers) and Congenital Heart Disease Studies (6 papers). I‐Chen Chen is often cited by papers focused on Pulmonary Hypertension Research and Treatments (8 papers), Trauma Management and Diagnosis (6 papers) and Congenital Heart Disease Studies (6 papers). I‐Chen Chen collaborates with scholars based in Taiwan. I‐Chen Chen's co-authors include Zen‐Kong Dai, Jong‐Hau Hsu, Jiunn‐Ren Wu, Yi‐Ching Liu, Chia‐Yang Li, Shu‐Chi Wang, Po‐Len Liu, Bin‐Nan Wu, Yu‐Hsin Tseng and Chee‐Yin Chai and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Medicine.

In The Last Decade

I‐Chen Chen

40 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Chen Chen Taiwan 13 135 86 73 55 54 43 346
Tamer A. Addissouky Iraq 12 53 0.4× 70 0.8× 80 1.1× 110 2.0× 33 0.6× 42 394
Lingyu Ding China 14 117 0.9× 102 1.2× 166 2.3× 21 0.4× 30 0.6× 40 620
Rob Spanjersberg Netherlands 9 50 0.4× 93 1.1× 46 0.6× 56 1.0× 51 0.9× 10 382
Emin Maden Türkiye 10 85 0.6× 30 0.3× 105 1.4× 146 2.7× 30 0.6× 28 373
Anna Solé Spain 11 53 0.4× 132 1.5× 55 0.8× 31 0.6× 25 0.5× 22 340
Joshua L. Rein United States 9 69 0.5× 69 0.8× 78 1.1× 24 0.4× 12 0.2× 21 384
Yaxiang Song China 11 50 0.4× 153 1.8× 82 1.1× 44 0.8× 8 0.1× 25 385
Vincenzo Schiavone Italy 12 43 0.3× 84 1.0× 205 2.8× 45 0.8× 37 0.7× 34 404
Dimitra Gialamprinou Greece 9 53 0.4× 92 1.1× 100 1.4× 109 2.0× 14 0.3× 26 370
Qingyu Zhao China 10 49 0.4× 98 1.1× 47 0.6× 40 0.7× 37 0.7× 19 445

Countries citing papers authored by I‐Chen Chen

Since Specialization
Citations

This map shows the geographic impact of I‐Chen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Chen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Chen Chen more than expected).

Fields of papers citing papers by I‐Chen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Chen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Chen Chen. The network helps show where I‐Chen Chen may publish in the future.

Co-authorship network of co-authors of I‐Chen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Chen Chen. A scholar is included among the top collaborators of I‐Chen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Chen Chen. I‐Chen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chia‐Yang, I‐Chen Chen, Po‐Len Liu, et al.. (2024). Protective effects of nordalbergin against LPS-induced endotoxemia through inhibiting MAPK/NF-κB signaling pathway, NLRP3 inflammasome activation, and ROS production. Inflammation Research. 73(10). 1657–1670. 3 indexed citations
2.
Tseng, Yu‐Hsin, et al.. (2023). Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome. International Journal of Molecular Sciences. 24(13). 10876–10876. 5 indexed citations
3.
Lee, Po‐Yen, I‐Chen Chen, Po‐Len Liu, et al.. (2023). Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. Biomedicine & Pharmacotherapy. 167. 115619–115619. 14 indexed citations
4.
Dai, Zen‐Kong, et al.. (2023). Mycoplasma pneumonia and its association with bronchial mucus plug formation. Pediatrics & Neonatology. 65(2). 198–199.
5.
Chen, I‐Chen, Yi‐Ching Liu, Jong‐Hau Hsu, et al.. (2022). Congenital Surfactant C Deficiency with Pulmonary Hypertension—A Case Report. Children. 9(10). 1435–1435. 1 indexed citations
6.
Liu, Yi‐Ching, Yu‐Wen Chen, I‐Chen Chen, et al.. (2022). Long-Term Study on Therapeutic Strategy for Treatment of Eisenmenger Syndrome Patients: A Case Series Study. Children. 9(8). 1217–1217. 2 indexed citations
7.
Chen, I‐Chen, Hsiu‐Lin Chen, Yi‐Ching Liu, et al.. (2022). Unique Pulmonary Hypertension in Young Children: A Case Series Study. Children. 9(7). 1064–1064. 2 indexed citations
8.
Liu, Yi‐Ching, et al.. (2022). A Rare Complication During Transcatheter Closure of Double Atrial Septal Defects With Incomplete Cor Triatriatum Dexter: A Case Report. Frontiers in Cardiovascular Medicine. 8. 815312–815312. 3 indexed citations
9.
Liu, Yi‐Ching, et al.. (2022). Case report: Transcatheter closure of a giant and tortuous right coronary artery to right ventricle fistula in an infant. Frontiers in Cardiovascular Medicine. 9. 898914–898914. 2 indexed citations
10.
Wang, Shu‐Chi, I‐Chen Chen, Yi‐Ting Chen, et al.. (2021). Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals. 14(6). 588–588. 27 indexed citations
11.
Chen, I‐Chen, et al.. (2021). Experience with outreach services of a multidisciplinary team for child abuse identification. Journal of the Formosan Medical Association. 121(6). 1111–1116. 3 indexed citations
12.
Lee, Po‐Yen, Shu‐Chi Wang, Po‐Len Liu, et al.. (2021). Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages. Toxins. 13(9). 593–593. 17 indexed citations
13.
Chen, I‐Chen, Yi‐Ching Liu, Chee‐Yin Chai, et al.. (2021). Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition. Frontiers in Medicine. 8. 619133–619133. 8 indexed citations
14.
Chen, I‐Chen, Jong‐Hau Hsu, & Zen‐Kong Dai. (2020). The diagnostic role of multidetector computed tomography in congenital tracheal agenesis. Pediatrics & Neonatology. 61(6). 650–652. 1 indexed citations
15.
Chen, I‐Chen, Ming‐Yen Lin, Yi‐Ching Liu, et al.. (2017). The role of transthoracic ultrasonography in predicting the outcome of community-acquired pneumonia in hospitalized children. PLoS ONE. 12(3). e0173343–e0173343. 8 indexed citations
16.
Chen, I‐Chen, et al.. (2011). Usefulness of combination of pulmonary ventilation and perfusion scintigraphy on the diagnosis of children with unilateral hyperlucent lung. Nuclear Medicine Communications. 32(11). 1052–1059. 6 indexed citations
17.
Chen, I‐Chen, et al.. (2010). Co‐existence of Posttraumatic Empyema Thoracis and Lung Abscess in a Child After Blunt Chest Trauma: A Case Report. The Kaohsiung Journal of Medical Sciences. 26(1). 45–49. 1 indexed citations
18.
Dai, Zen‐Kong, Bin‐Nan Wu, I‐Chen Chen, et al.. (2010). Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho‐kinase inhibitor fasudil. Pediatric Pulmonology. 46(1). 45–59. 15 indexed citations
19.
Chen, I‐Chen, et al.. (2010). Croup‐induced Postobstructive Pulmonary Edema. The Kaohsiung Journal of Medical Sciences. 26(10). 567–570. 1 indexed citations
20.
Chen, I‐Chen, et al.. (2010). Spontaneous Pneumomediastinum in Adolescents and Children. The Kaohsiung Journal of Medical Sciences. 26(2). 84–88. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026